Ekso Bionics Holdings's operating income is $-38M.
Get informed when a big investor buys or sells
+ FollowAs of Aug 31, 2026
Trailing 12 months ending Aug 31, 2026
As of the most recent data (August 2026), EKSO shows a operating income of $-38M. That compares with $-12M in the prior-year period — down 209.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, EKSO's operating income is now $-38M (was $-12M) — a 209.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ekso Bionics Holdings is outperforming or lagging.
Tracking EKSO's operating income over time shows whether Ekso Bionics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $-38M That compares with $-12M in the prior-year period — down 209.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Ekso Bionics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-38M) with ownership activity and broader fundamentals.
Ekso Bionics Holdings's operating income is $-38M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.